Adipose regeneration and implications for breast reconstruction: update and the futureEmerging metrology for high-throughput nanomaterial genotoxicologyDextran coated ultrafine superparamagnetic iron oxide nanoparticles: compatibility with common fluorometric and colorimetric dyesGenetic toxicity assessment of engineered nanoparticles using a 3D in vitro skin model (EpiDerm™)Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)High-resolution imaging using a novel atomic force microscope and confocal laser scanning microscope hybrid instrument: essential sample preparation aspects.Non-linear dose-response of DNA-reactive genotoxins: recommendations for data analysis.STEM mode in the SEM: a practical tool for nanotoxicology.Quantum dots for multiplexed detection and characterisation of prostate cancer cells using a scanning near-field optical microscope.Do dose response thresholds exist for genotoxic alkylating agents?Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma.The role of adhesion molecules as biomarkers for the aggressive prostate cancer phenotype.A role for STEAP2 in prostate cancer progression.Fluorescence in-situ hybridisation on biopsies from clam ileocystoplasties and on a clam cancer.Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus.Factors affecting the in vitro micronucleus assay for evaluation of nanomaterials.Pro-oxidant induced DNA damage in human lymphoblastoid cells: homeostatic mechanisms of genotoxic toleranceFluorescence in situ hybridisation analysis of chromosomal aberrations in gastric tissue: the potential involvement of Helicobacter pyloriCharacterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma.Aneuploidy in upper gastro-intestinal tract cancers--a potential prognostic marker?Early p53 mutations in nondysplastic Barrett's tissue detected by the restriction site mutation (RSM) methodology.Confounding experimental considerations in nanogenotoxicology.NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials.Genotoxic thresholds, DNA repair, and susceptibility in human populations.Automation and validation of micronucleus detection in the 3D EpiDerm™ human reconstructed skin assay and correlation with 2D dose responses.The clastogenicity of 4NQO is cell-type dependent and linked to cytotoxicity, length of exposure and p53 proficiency.Putative prognostic epithelial-to-mesenchymal transition biomarkers for aggressive prostate cancer.Bone morphogenic factor gene dosage abnormalities in prostatic intraepithelial neoplasia and prostate cancer.Comparative genomic hybridization (CGH) of augmentation cystoplasties.Analysis of the premalignant stages of Barrett's oesophagus through to adenocarcinoma by comparative genomic hybridization.Fluorescence imaging and investigations of directly labelled chromosomes using scanning near-field optical microscopy.A comparison of the genotoxicity of benzo[a]pyrene in four cell lines with differing metabolic capacity.Empirical analysis of BMD metrics in genetic toxicology part I: in vitro analyses to provide robust potency rankings and support MOA determinations.Genotoxic capacity of Cd/Se semiconductor quantum dots with differing surface chemistriesCell type-dependent changes in CdSe/ZnS quantum dot uptake and toxic endpoints.Acute dosing and p53-deficiency promote cellular sensitivity to DNA methylating agents.Genotoxins induce binucleation in L5178Y and TK6 cells.Recommendations, evaluation and validation of a semi-automated, fluorescent-based scoring protocol for micronucleus testing in human cells.Chromosome breakage induced by the genotoxic agents mitomycin C and cytosine arabinoside is concentration and p53 dependent.The in vitro micronucleus assay and kinetochore staining: methodology and criteria for the accurate assessment of genotoxicity and cytotoxicity.
P50
Q26751644-CC4111B1-FC5B-46DD-8C76-635871E22508Q28078427-B9012ED4-136A-4EA5-83F9-A18D8D4333C3Q28388585-A0EC02E5-61ED-466B-9AC7-17E8A63868ACQ28389006-5FE34079-EBF6-4F27-AE80-38DCDBCFA682Q28393651-913453C2-73A8-4D87-9BBA-B50F9536CD37Q30847383-F8EA4D54-677F-4B2A-8D91-AB8A51CCD361Q33452272-0985B65A-B64E-4255-A31E-7FBF8CC10C8BQ33751508-47EB729A-7728-434E-9C25-992CC5705B3DQ34162912-2A77A1C1-583D-4A78-A0F3-5C04E6CCD03AQ34447350-CAAC90E8-1BE8-4457-9E16-DB3B3F3658B3Q34703662-8FC88708-6127-475D-8329-30FA6BDA2C1CQ35072541-8FEDEA21-5C22-4198-B1AE-E955823307ADQ35271800-DCD449A3-2ADE-4A19-9BC3-1556103E75CAQ35551043-F0C740C9-A1DB-439B-B6C4-E496C5675959Q35595606-68AE64F6-EB32-49A7-9E66-A2AEF2AFD1A4Q36115060-7FC7E522-197D-48D2-9CB9-681BB78D8FF3Q36383647-8C633E82-4FB5-401E-AD67-B0940CC7E6CAQ36616789-56385E03-60F2-4D8E-8217-4F0F8258EC62Q36671507-AF0E9A91-001B-4C8B-B459-18257029BDA7Q37038010-7C0C94B1-8836-4AB5-B7D7-751FA9B064EAQ37355079-BB6EE2A9-3A1F-488D-AF10-2539C78F1198Q37436790-BDF6B2E8-B45E-4BCE-9E84-B741DA356FD5Q37475353-78046EED-C65A-468B-815C-45583E1AB79DQ37637248-E20AE6BA-817B-4801-9A56-7EB167FE6B47Q37698081-0DE1EEA1-D373-4868-96EF-3C73164376C5Q38332062-E2F1F6C9-70A8-4BF7-9A0A-FE626697CDD8Q38395325-7F855BF7-F1DF-46DD-A7BE-E378D7635C33Q38431156-45A259E9-8865-4CC7-8EFD-F07A9739B82DQ38431709-8A20F0BA-4C80-4C81-B99E-28C8E32CEC03Q38454443-B6118C42-0A15-432F-A596-C923C5B2D3E3Q38465791-4667A877-CE4A-4D8F-95D2-90E28459FEC2Q38745929-577D00B9-44AA-4783-A22C-F3870AE45B85Q38810274-4D8FBF69-6DFB-418C-A6B4-CE88F2DE724EQ38843709-0444E8CB-3492-4C51-A851-9A39C99E04D2Q38918519-FE03C610-55C7-49F8-9EEF-CA21874EB798Q38919228-E26924A5-1D82-488B-B185-4589816A4CEFQ38945276-113A64F0-4F87-4D91-ABEA-B4B96E5CB163Q39007296-DEF5813A-D575-4029-94C2-5AA684784E3EQ39011105-D1E36566-A7A2-49C1-98E7-ACD2A130CEBBQ39118485-C12FE3DF-FB5D-43AB-A492-B67BF3339C7F
P50
description
nanogenotoxicologist
@en
wetenschapper
@nl
name
Shareen Doak
@ast
Shareen Doak
@en
Shareen Doak
@es
Shareen Doak
@fr
Shareen Doak
@nl
Shareen Doak
@sl
type
label
Shareen Doak
@ast
Shareen Doak
@en
Shareen Doak
@es
Shareen Doak
@fr
Shareen Doak
@nl
Shareen Doak
@sl
prefLabel
Shareen Doak
@ast
Shareen Doak
@en
Shareen Doak
@es
Shareen Doak
@fr
Shareen Doak
@nl
Shareen Doak
@sl
P106
P1153
6603566002
P21
P31
P496
0000-0002-6753-1987
P569
1978-12-01T00:00:00Z